Acasti Pharma's (ACST) last three weeks of trading have been indicative of increasing investor interest. June 28th's closing at $2.83 represented a solid close above former resistance in the $2.70s that had been the stock's bane since December 2012, January of this year and multiple times in May and June. Reviewing the company's stock chart for 2013, March 21st's $2.10 closing lows have been followed by a bullish uptrend with 52-week closing highs of $3.00 on July 8th. When researching new investment candidates, SEC filings and corporate press releases around such peaks and dips can be very revealing and can reveal upcoming or even imminent catalysts. Although currently a somewhat illiquid stock, I believe investors with a higher...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|